Evidence map›Paper›PMID 35222678›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2022

Taxonomical Investigation, Chemical Composition, Traditional Use in Medicine, and Pharmacological Activities of

Mansour Miran, Keyvan Amirshahrokhi, Yousef Ajanii, Reza Zadali, Maxwell W Rutter, Ayesheh Enayati, Farahnaz Movahedzadeh

Abstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Effect of Supplementing Milk Replacer withAnimals : an open access journal from MDPI · 2026
    Article
  3. Qualitative phytochemical profiling, antioxidant activity, and development of a water-in-oil cream containing combined oil and water infusions of frankincense resin (Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Article
  4. Article
  5. Frontiers in pharmacology · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Improved antimicrobial activities ofNanoscale advances · 2024
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mansour MiranDepartment of Pharmacognosy, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0000-0002-3156-9123
Keyvan AmirshahrokhiDepartment of Pharmacology, School of Pharmacy, Ardabil University of Medical Science, Ardabil, Iran.
Yousef AjaniiBotany Division, Research Institute of Forests and Rangelands, Agricultural Research Education and Extension Organization (AREEO), Tehran, Iran.
Reza ZadaliDepartment of Pharmacognosy, Faculty of Pharmacy, Islamic Azad University-Damghan Branch, Iran.
Maxwell W RutterHollingbery & Son, Inc, Yakima, WA 98902, USA.
Ayesheh EnayatiIschemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Farahnaz MovahedzadehInstitute for Tuberculosis Research, University of Illinois at Chicago, Chicago, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aromatic oleo-gum-resin secreted from

Identifiers

PMID35222678
PMCPMC8881160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.